Valuation : Celltrion, Inc.

Market Cap 43,944B 32.75B 28.16B 26.49B 24.18B 45.12B 3,105B 45.35B 314B 121B 1,587B 123B 120B 5,050B P/E 2026 *
27.8x
P/E 2027 * 23.8x
Enterprise Value 46.16B 34.4M 29.58M 27.83M 25.39M 47.39M 3.26B 47.64M 330M 128M 1.67B 129M 126M 5.3B EV / Sales 2026 *
8.36x
EV / Sales 2027 * 7.15x
Free-Float
60.59%
Yield 2026 *
0.41%
Yield 2027 * 0.45%
1 day-1.72%
1 week-2.61%
Current month-3.07%
1 month-8.13%
3 months+14.87%
6 months-9.53%
Current year+6.22%
1 week 182,900
Extreme 182900
191,100
1 month 182,900
Extreme 182900
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.72%-2.61%+13.09%+42.33% 33.21B
-0.82%-3.77%-2.49%+14.92% 48.41B
-1.29%-1.22%+404.92%+545.45% 45.01B
-3.20%+0.33%+38.11%+21.39% 44.07B
-1.89%-2.00%+1.45%+82.46% 40.73B
-0.17%+3.78% - - 17.77B
-0.07%+1.32%+20.08%+117.95% 16.5B
-0.56%-0.50%+11.39%+31.41% 14.45B
-2.68%-0.56%+73.31%+40.56% 13.77B
-3.95%-1.90%-10.95%-36.70% 12.72B
Average -1.64%-0.42%+60.99%+95.53% 28.67B
Weighted average by Cap. -1.65%-0.85%+80.51%+124.50%

Financials

2026 *2027 *
Net sales 5,518B 4.11B 3.54B 3.33B 3.04B 5.67B 390B 5.69B 39.42B 15.25B 199B 15.44B 15.11B 634B 6,337B 4.72B 4.06B 3.82B 3.49B 6.51B 448B 6.54B 45.27B 17.51B 229B 17.74B 17.35B 728B
Net income 1,536B 1.14B 984M 926M 845M 1.58B 108B 1.58B 10.97B 4.24B 55.46B 4.3B 4.2B 176B 1,785B 1.33B 1.14B 1.08B 982M 1.83B 126B 1.84B 12.75B 4.93B 64.46B 5B 4.89B 205B
Net Debt 2,215B 1.65B 1.42B 1.34B 1.22B 2.27B 156B 2.29B 15.82B 6.12B 79.98B 6.2B 6.06B 255B 1,355B 1.01B 868M 817M 745M 1.39B 95.74B 1.4B 9.68B 3.74B 48.93B 3.79B 3.71B 156B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-08 ₩183,100.00 -1.72% 482,451
26-09-07 ₩186,300.00 -0.96% 408,399
26-09-04 ₩188,100.00 +0.53% 270,580
26-09-03 ₩187,100.00 +0.43% 406,507
26-09-02 ₩186,300.00 -0.90% 299,403
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
183,100.00KRW
Average target price
268,232.21KRW
Spread / Average Target
+46.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!